Varion Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Revenue Growth -20.88%
- Profit Growth -27.86%
- Ebitda -363.98%
- Net Worth 4.13%
- Total Assets 14.41%
About Varion Lifesciences
Varion Lifesciences Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2006 and has a history of 19 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Varsha Kumar and Sanjay Kumar serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U47219MH2006PTC159127
- Company No.
159127
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Varion Lifesciences Private Limited offer?
Varion Lifesciences Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Herbal Extracts, Homeopathic Drugs, Homeopathic Ointment, Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Chemical Reagents & Catalysts, Organic Compounds, Plant Extracts, Skin Lightening Drugs.
Who are the key members and board of directors at Varion Lifesciences?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Varsha Kumar | Director | 20-Jan-2006 | Current |
Sanjay Kumar | Director | 25-Jan-2016 | Current |
Financial Performance of Varion Lifesciences.
Varion Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.88% decrease. The company also saw a substantial fall in profitability, with a 27.86% decrease in profit. The company's net worth moved up by a moderate rise of 4.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Varion Lifesciences?
In 2021, Varion Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
07 Mar 2019 | Others | ₹4.00 M | Open |
How Many Employees Work at Varion Lifesciences?
Unlock and access historical data on people associated with Varion Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Varion Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Varion Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.